TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
INVA

Innoviva Inc

Healthcare · Biotechnology

20.20$ -3.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INVA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
48.3% 50.5% 52.3% 54.3% 36.3% 59.5% 34.2% 33.9% 36.0% 27.7% 42.6% 44.5%
18.6% 37.5% 31.1% 20.0% 11.4% 38.4% 24.7% 21.8% 23.6% 15.6% 23.4% 33.7%
46.1% 44.2% 39.7% 35.1% 21.0% 48.4% 24.7% 21.8% 23.6% 15.6% 31.7% 33.7%
2.0% 6.2% 12.4% 19.2% 15.2% 11.0% 9.4% 12.0% 5.2% 6.8% 6.6% 2.1%
0.0% -6.2% -12.4% -0.2% -15.2% -11.0% -9.4% -12.0% 4.5% 3.3% 2.6% 2.4%
0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.3% – – –
0.0% 0.0% 0.0% 0.0% – – – 10.9% 2.2% 1.4% 1.4% 1.1%
0.1% 45.8% 47.6% 45.4% 27.9% 19.2% 9.4% 1.1% 20.5% 18.5% 16.0% 11.1%
142.8% 177.2% 193.1% 166.1% 71.0% 52.8% 39.2% 43.2% 54.1% 45.7% 46.9% 28.3%
2.6% 3.2% 5.3% 9.5% 1.0% 0.7% 0.6% 0.6% 11.0% 3.1% 18.1% 3.0%
139.1% 1.5% 2.0% 6.8% – – 2.5% 0.0% 7.9% 0.1% 14.9% 0.0%
0.0% 0.2% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.2% 0.5% 0.2% 0.3%
139.1% 172.9% 186.9% 156.4% 69.8% 52.0% 38.6% 42.6% 43.9% 35.9% 19.7% 15.8%
-42.8% -80.8% -93.1% -66.1% 28.0% 43.3% 60.8% 44.8% 45.9% 54.3% 53.1% 71.7%
-320.8% -399.1% -430.8% -408.0% -201.3% -130.6% -72.2% -49.2% -16.6% -2.0% -0.1% 16.5%
21.5% 27.2% 32.5% 32.6% 20.7% 15.6% 11.4% 10.2% 7.7% 7.0% 5.7% 5.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?